Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer-Reference-Cited by-同舟云学术

Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer

Published:2011-09 Issue:18 Volume:21 Page:5442-5445
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Bradbury Robert H.,Hales Neil J.,Rabow Alfred A.,Walker Graeme E.,Acton David G.,Andrews David M.,Ballard Peter,Brooks Nigel A.N.,Colclough Nicola,Girdwood Alan,Hancox Urs J.,Jones Owen,Jude David,Loddick Sarah A.,Mortlock Andrew A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. ATREUS ARTIFEX (SENECA, THYESTES 906–7)

2. The development of androgen-independent prostate cancer

3. Targeting the androgen receptor pathway in prostate cancer

4. Androgen receptor: role and novel therapeutic prospects in prostate cancer

5. Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer;Journal of Medicinal Chemistry;2024-07-11

2. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders;European Journal of Medicinal Chemistry;2024-02

3. Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer;eLife;2023-01-19

4. Synthesis, Characterization, and Computational Studies of Some Perfluorinated Cyclopentapyridazines for Biological Applications;HETEROCYCLES;2023

5. Stability of Steroid Hormone Receptors;Protein Homeostasis in Drug Discovery;2022-11-14